SCHEMBL14236575

SCHEMBL14236575

c1ncc2c(-c3ncc(N4CCCCC4)cn3)c[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 12/20 0.44
▸ ROCK1 Q13464 12/20 0.44
▸ CDC42BPB Q9Y5S2 12/20 0.44
▸ CDC42BPA Q5VT25 4/20 0.44
▸ RPS6KA5 O75582 1/20 0.42
▸ LRRK2 Q5S007 3/20 0.40
▸ STK3 Q13188 2/20 0.40
▸ CDC7 O00311 1/20 0.40
▸ ROS1 P08922 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ MARK3 P27448 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ MAP2K1 Q02750 1/20 0.40
▸ MAP3K10 Q02779 1/20 0.40
▸ MELK Q14680 1/20 0.40
▸ MARK4 Q96L34 1/20 0.40
▸ CAMKK2 Q96RR4 1/20 0.40
▸ SIK2 Q9H0K1 1/20 0.40
▸ CAMK2A Q9UQM7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5075075 0.79 RPS6KA5 (0.41) ROCK2ROCK1CDC42BPBCDC42BPARPS6KA5
SCHEMBL14236254 0.76 LATS1 (0.41) ROCK2ROCK1CDC42BPBCDC42BPARPS6KA5
SCHEMBL16343917 0.69 GSK3B (0.47) ROCK2ROCK1CDC42BPBCDC42BPAJAK3
SCHEMBL19068207 0.68 NTRK1 (0.53) ROCK2ROCK1CDC42BPBCDC42BPAKIT
SCHEMBL14237922 0.67 LATS1 (0.49) ROCK2ROCK1CDC42BPBCDC42BPARPS6KA5
SCHEMBL14236205 0.67 RPS6KA5 (0.47) ROCK2ROCK1RPS6KA5CDC7FLT3
SCHEMBL19068211 0.67 AXL (0.59) ROCK2LRRK2STK3CDC7ROS1
SCHEMBL19068203 0.67 NTRK1 (0.54) KITCDK8
SCHEMBL19325116 0.66 KMT2A (0.49) ROCK2ROCK1FLT3
SCHEMBL18235303 0.66 CHKA (0.50) ROCK2ROCK1CDC42BPBCDC42BPA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2532667-A1 Deazapurines useful as inhibitors of janus kinases Vertex Pharmaceuticals Incorporated (US) 2012-12-12 — — EP disclosed
Send feedback